DK145341C - Analogifremgangsmaade til fremstilling af pyridylguanidiner - Google Patents

Analogifremgangsmaade til fremstilling af pyridylguanidiner

Info

Publication number
DK145341C
DK145341C DK572975A DK572975A DK145341C DK 145341 C DK145341 C DK 145341C DK 572975 A DK572975 A DK 572975A DK 572975 A DK572975 A DK 572975A DK 145341 C DK145341 C DK 145341C
Authority
DK
Denmark
Prior art keywords
pyridylguanidines
analogy
preparation
Prior art date
Application number
DK572975A
Other languages
English (en)
Other versions
DK145341B (da
DK572975A (da
Inventor
H J Petersen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of DK572975A publication Critical patent/DK572975A/da
Publication of DK145341B publication Critical patent/DK145341B/da
Application granted granted Critical
Publication of DK145341C publication Critical patent/DK145341C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
DK572975A 1974-12-20 1975-12-17 Analogifremgangsmaade til fremstilling af pyridylguanidiner DK145341C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB55209/74A GB1489879A (en) 1974-12-20 1974-12-20 N'-cyano-n'-3-pyridylguanidines
GB5520974 1974-12-20

Publications (3)

Publication Number Publication Date
DK572975A DK572975A (da) 1976-06-21
DK145341B DK145341B (da) 1982-11-01
DK145341C true DK145341C (da) 1983-03-28

Family

ID=10473276

Family Applications (1)

Application Number Title Priority Date Filing Date
DK572975A DK145341C (da) 1974-12-20 1975-12-17 Analogifremgangsmaade til fremstilling af pyridylguanidiner

Country Status (22)

Country Link
US (2) US4057636A (da)
JP (1) JPS6028819B2 (da)
AT (1) AT346357B (da)
BE (1) BE836885A (da)
CA (1) CA1067083A (da)
CH (1) CH618429A5 (da)
DD (1) DD122529A5 (da)
DE (2) DE2557438A1 (da)
DK (1) DK145341C (da)
ES (1) ES443725A1 (da)
FI (1) FI60560C (da)
FR (1) FR2294703A1 (da)
GB (1) GB1489879A (da)
IE (1) IE42141B1 (da)
IT (1) IT1062213B (da)
LU (1) LU74071A1 (da)
NL (1) NL184109C (da)
PH (1) PH12506A (da)
SE (1) SE424637B (da)
SU (1) SU683615A3 (da)
YU (1) YU39754B (da)
ZA (1) ZA757481B (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562066A (en) * 1978-11-03 1980-05-10 Toshihiko Okamoto N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives
IE52935B1 (en) * 1981-04-15 1988-04-13 Leo Pharm Prod Ltd Pharmaceutical preparation
IE54196B1 (en) * 1981-09-10 1989-07-19 Leo Pharm Prod Ltd Chemical compounds
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
EP0579260A1 (en) * 1987-07-07 1994-01-19 Beecham Group Plc Use of a vasodilator for the treatment of pulmonary hypertension and/or right heart failure-related conditions
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
US5244664A (en) * 1988-01-21 1993-09-14 Leo Pharmaceutical Products Ltd. Topical preparation for treatment of alopecia
GB8801318D0 (en) * 1988-01-21 1988-02-17 Leo Pharm Prod Ltd Pharmaceutical preparations
AU3693789A (en) * 1988-05-10 1989-11-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) New ophthalmic preparation for treating glaucoma
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
JP2884412B2 (ja) * 1988-10-21 1999-04-19 日本バイエルアグロケム株式会社 殺虫性シアノ化合物
US5264445A (en) * 1989-02-03 1993-11-23 Eli Lilly And Company (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine
AU623217B2 (en) * 1989-02-03 1992-05-07 Eli Lilly And Company (-)-n"-cyano-n-3-pyridyl-n'-1,2,2-trimethyl- propylguanidine, a process for preparing the compound, and use of the compound as a medicament
EP0407346A3 (en) * 1989-07-07 1991-10-02 Ciba-Geigy Ag Aminopyridines
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
US5217982A (en) * 1990-09-25 1993-06-08 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive properties
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
EP0618798B1 (en) * 1991-12-23 1997-03-12 PHARMACIA & UPJOHN COMPANY Pyridylguanidine compounds for treatment of erectile dysfunction
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
AU4530693A (en) * 1992-08-13 1994-03-15 Upjohn Company, The Cyanoguanidines as potassium channel blockers
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
JPH06228100A (ja) * 1992-12-07 1994-08-16 Green Cross Corp:The 光学活性アミノピリジン誘導体およびその用途
EP0703904B1 (en) * 1993-06-11 1999-02-24 PHARMACIA & UPJOHN COMPANY Pyrimidine cyanoguanidines as k-channel blockers
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5633374A (en) * 1993-11-26 1997-05-27 The Upjohn Company Pyrimidine, cyanoguanidines as K-channel blockers
ATE166343T1 (de) * 1994-01-28 1998-06-15 Upjohn Co Cyanoguanidine als k-kanal-blocker
US5525742A (en) * 1994-06-10 1996-06-11 The Upjohn Company Azidophenylcyanoguanidines as photoaffinity probes
US5856449A (en) * 1994-11-17 1999-01-05 Pharmacia & Upjohn Company Protein affecting KATP channels
JP2000516621A (ja) * 1996-08-15 2000-12-12 スミスクライン・ビーチャム・コーポレイション Il―8レセプターアンタゴニスト
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
US6458835B2 (en) 1997-08-13 2002-10-01 Bristol-Myers Squibb Company Method of inhibiting or treating chemotherapy-induced hair loss
US6013668A (en) * 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
AU9211098A (en) * 1997-09-03 1999-03-22 American Home Products Corporation Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents
WO2000061561A1 (en) 1999-04-09 2000-10-19 Shionogi Bioresearch Corp. Cyanoguanidine compounds
GB9908410D0 (en) 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
PL374758A1 (en) * 2002-10-24 2005-10-31 Merck Patent Gmbh Methylene urea derivatives
US9296697B2 (en) * 2005-08-24 2016-03-29 Abbott Laboratories Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors
US20070250567A1 (en) * 2006-04-20 2007-10-25 Graham Philip R System and method for controlling a telepresence system
WO2009089053A1 (en) * 2008-01-11 2009-07-16 Nektar Therapeutics Al, Corporation Oligomer-guanidine class conjugates
PL2649048T3 (pl) * 2010-12-09 2016-10-31 Wielofunkcyjne pochodne nitroksydu i ich zastosowania
EP4025300A1 (en) * 2019-09-03 2022-07-13 Salzman Group Ltd. Atp-regulated potassium channel openers comprising guanidine and uses thereof
WO2023176554A1 (ja) * 2022-03-14 2023-09-21 国立大学法人東北大学 認知機能改善剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036083A (en) * 1959-05-15 1962-05-22 Ciba Geigy Corp Certain 2-pyridyl lower alkyl guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines

Also Published As

Publication number Publication date
DK145341B (da) 1982-11-01
ES443725A1 (es) 1977-04-16
DK572975A (da) 1976-06-21
NL184109C (nl) 1989-04-17
IE42141B1 (en) 1980-06-04
FI753520A (da) 1976-06-21
SE424637B (sv) 1982-08-02
JPS6028819B2 (ja) 1985-07-06
US4057636A (en) 1977-11-08
AU8712775A (en) 1977-06-09
ZA757481B (en) 1977-01-26
IE42141L (en) 1976-06-20
ATA936075A (de) 1978-03-15
DE2557438C2 (da) 1989-01-05
DE2557438A1 (de) 1976-06-24
NL7514852A (nl) 1976-06-22
JPS5186474A (da) 1976-07-29
PH12506A (en) 1979-04-18
FI60560B (fi) 1981-10-30
USRE31244E (en) 1983-05-17
FR2294703A1 (fr) 1976-07-16
FR2294703B1 (da) 1980-06-27
SU683615A3 (ru) 1979-08-30
SE7514153L (sv) 1976-06-21
DE2560633C2 (da) 1988-09-08
AT346357B (de) 1978-11-10
IT1062213B (it) 1983-09-20
YU316275A (en) 1982-02-28
BE836885A (fr) 1976-06-21
YU39754B (en) 1985-04-30
CA1067083A (en) 1979-11-27
LU74071A1 (da) 1976-11-11
CH618429A5 (da) 1980-07-31
FI60560C (fi) 1982-02-10
NL184109B (nl) 1988-11-16
DD122529A5 (da) 1976-10-12
GB1489879A (en) 1977-10-26

Similar Documents

Publication Publication Date Title
DK145341C (da) Analogifremgangsmaade til fremstilling af pyridylguanidiner
DK173675A (da) Fremgangsmade til fremstilling af mangandioxid
DK151013C (da) Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider
DK429175A (da) Katalysatorer til hydroomdannelse af carbonhydrider
DK150155C (da) Analogifremgangsmaade til fremstilling af benzocycloamid-derivater
DK251875A (da) Fremgangsmade til kontinuerlig forestering af chlorsilaner
DK249975A (da) Fremgangsmade til fremstilling af 8-thiomethylergolin-forbindelser
DK464175A (da) Fremgangsmade til kontinuerlig fremstilling af lineere polyestere
DK144298C (da) Fremgangsmaade til fremstilling af alkyl-tert-butylethere
DK136398C (da) Fremgangsmaade til fremstilling af et analgetisk-antipyretisk praeparat
DK254975A (da) Fremgangsmade til fremstilling af aminotetralolforbindelser
DK152765C (da) Fremgangsmaade til fremstilling af d-(-)-n-carbamylphenylglycin
DK145099C (da) Analogifremgangsmaade til fremstilling af pyridazinderivater
DK292375A (da) Fremgangsmade til fremstilling af gipsprodukter
DK143902C (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
DK225075A (da) Fremgangsmade til fremstilling af alfa-6--desoxy5-hydroxytetracyclin
DK141849C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK142455C (da) Analogifremgangsmaade til fremstilling af thiaprostaglandiner
DK153389C (da) Fremgangsmaade til fremstilling af pinacolon
DK146718C (da) Analogifremgangsmaade til fremstilling af benzobicyklononener
DK402875A (da) Fremgangsmade til fremstilling af meta-substituerede halogenphenoler
DK405775A (da) Fremgangsmade til fremstilling af alkanolaminer
DK216575A (da) Fremgangsmade til fremstilling af methylaminderivater
DK162280C (da) Fremgangsmaade til fremstilling af 3-formylpinan
DK585875A (da) Fremgangsmade til fremstilling af substituerede 3-methylencephamsulfoxider

Legal Events

Date Code Title Description
PUP Patent expired